HCPCS codes

22720 HCPCS codes with hospital pricing data in the network.

• HCPCS J9301 — Obinutuzumab injection, per 10 mgAI (1826 hospitals, 1,623,001–1,624,009 samples)
• HCPCS J0567 — Injection of cerliponase alfa, per 1 mgAI (1029 hospitals, 1,620,536–1,620,572 samples)
• HCPCS J1050 — Medroxyprogesterone acetate 150 mg/mL injectionAI (2133 hospitals, 1,532,499–1,542,696 samples)
• HCPCS J1644 — Heparin sodium injection, 5000 units per mLAI (2420 hospitals, 1,229,840–1,534,580 samples)
• HCPCS A4649 — Waterproof foam dressing, 2 by 3 inchesAI (1087 hospitals, 169,445–1,499,726 samples)
• HCPCS J1100 — Dexamethasone sodium phosphate injection, 4 mg per mLAI (2462 hospitals, 1,190,980–1,490,518 samples)
• HCPCS J7170 — Emicizumab injection, 0.5 mgAI (1240 hospitals, 1,487,453 samples)
• HCPCS P9047 — Human albumin 25% injectionAI (2286 hospitals, 1,284,102–1,355,535 samples)
• HCPCS J0133 — Acyclovir intravenous antiviral solutionAI (2295 hospitals, 1,351,626–1,355,496 samples)
• HCPCS C1729 — Nephrostomy set, 8.2 French by 15 cmAI (2150 hospitals, 140,255–1,257,443 samples)
• HCPCS J1308 — Famotidine injection 20 mg/2 mL, preservative-freeAI (1964 hospitals, 1,145,082–1,165,026 samples)
• HCPCS J2405 — Ondansetron injection 4 mgAI (2451 hospitals, 974,341–1,153,864 samples)
• HCPCS J1953 — Levetiracetam injectionAI (2365 hospitals, 1,101,801–1,138,440 samples)
• HCPCS Q5119 — Rituximab-pvvr biosimilar injection (Ruxience), per 10 mgAI (1942 hospitals, 1,087,287–1,090,239 samples)
• HCPCS C1876 — Vascular stent, 6 French, 7 x 80 mmAI (1930 hospitals, 108,228–1,072,443 samples)
• HCPCS A9270 — NON-COVERED ITEM OR SERVICEAI (802 hospitals, 242,893–1,017,505 samples)
• HCPCS J8540 — Dexamethasone 4 mg tabletAI (2221 hospitals, 888,524–1,007,702 samples)
• HCPCS J0257 — Alpha-1 proteinase inhibitor injection, 10 mgAI (1355 hospitals, 1,005,630–1,005,666 samples)
• HCPCS C1751 — Intravascular catheter, 18 gauge, 2.25 inchAI (2255 hospitals, 116,453–1,005,176 samples)
• HCPCS A9573 — Gadopiclenol contrast injection, per milliliterAI (1201 hospitals, 991,809–994,284 samples)
• HCPCS J0690 — Cefazolin sodium injection 1 gramAI (2424 hospitals, 798,590–953,399 samples)
• HCPCS C1789 — Smooth low-profile rectangular tissue expander, 160-320 ccAI (1716 hospitals, 98,358–950,091 samples)
• HCPCS J2250 — Midazolam injection, various strengths and syringesAI (2422 hospitals, 709,583–946,742 samples)
• HCPCS J3475 — Magnesium sulfate injection 50%AI (2424 hospitals, 715,090–916,870 samples)
• HCPCS J3010 — Fentanyl citrate injection, preservative-free, various strengthsAI (2438 hospitals, 576,214–899,665 samples)
• HCPCS J7121 — 5% dextrose in lactated Ringer's solutionAI (1888 hospitals, 876,787–882,880 samples)
• HCPCS J9171 — Injection of docetaxel, per milligramAI (2093 hospitals, 853,078–866,731 samples)
• HCPCS J7060 — Dextrose 5% intravenous solutionAI (2180 hospitals, 836,885–865,253 samples)
• HCPCS J0256 — Alpha-1 proteinase inhibitor injection, per 10 mgAI (1777 hospitals, 861,724–864,532 samples)
• HCPCS J3032 — Eptinezumab injection, per 1 mgAI (1759 hospitals, 854,636–856,958 samples)
• HCPCS C1726 — Balloon catheter for kidney proceduresAI (2140 hospitals, 98,852–848,453 samples)
• HCPCS C1762 — Femoral cortical bone allograft strut, 100 x 20 mmAI (1859 hospitals, 79,830–763,353 samples)
• HCPCS A9577 — MultiHance contrast agent injection, 15 mLAI (1727 hospitals, 696,542–714,380 samples)
• HCPCS J1071 — Testosterone cypionate injectionAI (2033 hospitals, 695,242–697,438 samples)
• HCPCS J0585 — Onabotulinumtoxin A injection, 100 unitsAI (2228 hospitals, 669,592–686,791 samples)
• HCPCS J1010 — Methylprednisolone acetate injection, 40 mg per mLAI (2318 hospitals, 601,327–666,982 samples)
• HCPCS C1768 — Pulmonary artery graft, 16 mm or smallerAI (1835 hospitals, 67,040–660,977 samples)
• HCPCS J1885 — Ketorolac injection, 30 mg per mLAI (2487 hospitals, 467,370–655,263 samples)
• HCPCS J9034 — Bendamustine hydrochloride injection, per milligramAI (1811 hospitals, 647,275–647,788 samples)
• HCPCS J9316 — Pertuzumab, trastuzumab and hyaluronidase injection (Phesgo)AI (1535 hospitals, 636,008–637,340 samples)
• HCPCS G2211 — Complex office visit add-onAI (925 hospitals, 616,728–628,455 samples)
• HCPCS A4648 — Breast biopsy site marker (SecurMark)AI (2100 hospitals, 88,888–627,223 samples)
• HCPCS J1815 — Regular human insulin injection, 100 units per mLAI (2309 hospitals, 475,085–581,429 samples)
• HCPCS J1171 — Hydromorphone injection 2 mg/mLAI (2258 hospitals, 292,472–568,052 samples)
• HCPCS V2787 — Intraocular lens implant, 16.5 diopter Tecnis toricAI (1360 hospitals, 56,731–562,243 samples)
• HCPCS Q9961 — High-osmolar iodine contrast dye, per milliliterAI (1339 hospitals, 526,604–527,558 samples)
• HCPCS J1569 — Gammagard liquid injectionAI (2026 hospitals, 498,816–501,696 samples)
• HCPCS J0696 — Ceftriaxone sodium injection, 2 gram vialAI (2443 hospitals, 213,635–488,981 samples)
• HCPCS J2919 — Methylprednisolone sodium succinate injection, 1000 mgAI (2333 hospitals, 210,126–487,488 samples)
• HCPCS Q5107 — Bevacizumab-awwb (Mvasi) injection, per 10 mgAI (1854 hospitals, 480,616–483,262 samples)